Bibliographic Details
| Title: |
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor. |
| Authors: |
Jani JP; Department of Cancer Discovery, Pfizer Global Research and Development, Groton, Connecticut 06340, USA., Finn RS, Campbell M, Coleman KG, Connell RD, Currier N, Emerson EO, Floyd E, Harriman S, Kath JC, Morris J, Moyer JD, Pustilnik LR, Rafidi K, Ralston S, Rossi AM, Steyn SJ, Wagner L, Winter SM, Bhattacharya SK |
| Source: |
Cancer research [Cancer Res] 2007 Oct 15; Vol. 67 (20), pp. 9887-93. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
